Search for cancer prevention, treatment and quality of life studies enrolling people with or at high risk for hereditary cancers.
Sign up for hereditary cancer research updates.
Search Results: Treatment + Prostate Cancer + Newly Diagnosed (3 results)
Treatment
Treatment study for people with intermediate- or high-risk prostate cancer with certain tumor mutations
NePtune: Using PARP Inhibitors Before Surgery in Localized Prostate Cancer
This research study is enrolling prostate cancer patients who plan to undergo surgery to have their prostate removed (radical prostatectomy) and whose cancer has one of the listed gene mutations: BRCA1, BRCA2, PALB2, RAD51B, RAD51C, RAD51D, RAD54L2, BARD1, FANCA or BRIP1.
Treatment
Treatment before surgery for people with high-risk prostate cancer and an inherited BRCA1 or BRCA2 gene mutation
Carboplatin Chemotherapy before Surgery for Patients with High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
This study tests how well carboplatin before surgery works in treating patients with high-risk prostate cancer who have inherited BRCA1 or BRCA2 gene mutations. The purpose of the study is to treat men with BRCA1 or BRCA2 mutations who are at higher risk of prostate cancer after surgery (removal of the prostate) compared to patients without these mutations.
Treatment
A Randomized Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Metastatic Breast, Ovarian, Prostate and Pancreatic Cancer Patients
Genetic testing can be helpful to identify potential targeted treatments for some patients with metastatic cancer. But some patients have a hard time getting easy and fast testing. This study is looking at using web options to increase access to testing AND patients in this study can get genetic counseling and testing in their home!
Additional Results on Clinicaltrials.gov Treatment + Prostate Cancer + Newly Diagnosed + test
9 results
Research Search Tool Sponsored By:
